Jason Wittes Analyst Performance Managing Director at Roth CapitalJason Wittes is a stock analyst at Roth Capital in the healthcare sector, covering 20 publicly traded companies. While full access to Jason Wittes' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Wittes' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings74 Last 11 YearsBuy Recommendations78.08% 57 Buy RatingsCompanies Covered20 Unique Companies Ratings Distribution73RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason Wittes.RatingPercentageCount Strong Buy2.7%2 ratings Buy75.3%55 ratings Hold16.4%12 ratings Sell5.5%4 ratingsOut of 73 total stock ratings issued by Jason Wittes at Roth Capital, the majority (75.3%) have been Buy recommendations, followed by 16.4% Hold, 5.5% Sell, and 2.7% Strong Buy.Best & Worst CallsBest Call0000.0%LMATJul 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%XTNTMar 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ60.0% of companies on NASDAQ12 companiesNYSE30.0% of companies on NYSE6 companiesNYSEAMERICAN5.0% of companies on NYSEAMERICAN1 companyOTCMKTS5.0% of companies on OTCMKTS1 companyJason Wittes, an analyst at Roth Capital, currently covers 20 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare20 companies100.0%Jason Wittes of Roth Capital specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES14 companies70.0%BIOTECHNOLOGY4 companies20.0%PHARMACEUTICALS2 companies10.0% Jason Wittes' Ratings History at Roth Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCVCapsoVision11/4/2025Set Price Target$4.78$7.00$0.0000.00% ROISPRYARS Pharmaceuticals11/4/2025Initiated Coverage$8.62$30.00Buy$0.0000.00% ROICVCapsoVision11/4/2025Upgrade$4.59Strong-Buy$0.0000.00% ROISPRYARS Pharmaceuticals9/4/2025Initiated Coverage$10.88$40.00Buy$0.0000.00% ROICVCapsoVision7/28/2025Set Price Target$4.00$6.00Buy$0.0000.00% ROICVCapsoVision7/28/2025Upgrade$4.35$6.00Strong-Buy$0.0000.00% ROISYKStryker5/2/2025Boost Price Target$377.63$456.00Buy$000.0000.00% ROIALURAllurion Technologies3/21/2025Reiterated Rating$47.52$240.00Buy$00.0000.00% ROIFBIOFortress Biotech3/11/2025Reiterated Rating$1.75$16.00Buy$0.0000.00% ROIOFIXOrthofix Medical2/26/2025Reiterated Rating$17.07$22.00Buy$00.0000.00% ROIIRMDiRadimed2/14/2025Reiterated Rating$55.53$72.00Buy$00.0000.00% ROITLSITriSalus Life Sciences1/24/2025Reiterated Rating$5.17$11.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftRaymond James FinancialMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
